In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Gleb K RystsovG.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino 142290, Russia.ORCID 0000-0001-5498-9932 Tatiana V AntipovaG.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino 142290, Russia.ORCID 0000-0002-4860-2647 Zhanna V RenfeldG.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino 142290, Russia.ORCID 0000-0002-4032-3678 Lidiya S PilguyG.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino 142290, Russia.
Michael G ShlyapnikovG.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino 142290, Russia.
Mikhail B VainshteinG.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino 142290, Russia.ORCID 0000-0001-5127-3621 Igor E GranovskyG.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino 142290, Russia.ORCID 0000-0003-1368-2146 Marina Y ZemskovaG.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Pushchino 142290, Russia.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
The secondary metabolites of the fungus
Indexed as
Antineoplastic AgentsEpithelial-Mesenchymal TransitionPenicilliumQuinazolinesTriple Negative Breast NeoplasmsCell Line, TumorCell MovementCell ProliferationFemaleHumansMCF-7 CellsMDA-MB-231 CellsAntineoplastic AgentsQuinazolinesanticancer activityCD44epithelial–mesenchymal transitionfumiquinazolines F and GMDA-MB-231 triple-negative breast cancer cellsP. thymicolaquinoline alkaloids
Identifiers
PMID40806710
PMCPMC12347039
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390